"dr-reddys-laboratories"

This will be a multi-centre and randomised controlled study, which will include safety and immunogenicity study, Dr Reddy’s said in a statement.

The company has committed to reduce Scope 1 and 2 greenhouse gas (GHG) emissions by 55 per cent by 2030 from a FY2017-18 base year.